Ep 84 | CMS OPPS Drug Acquisition Cost Survey (ODACS)

Ep 84 | CMS OPPS Drug Acquisition Cost Survey (ODACS)

In this episode, Rob and Greg are joined by guest Andy Ruskin, healthcare attorney and government payer expert from K&L Gates. They’ll be discussing the 2026 CMS OPPS Final Rule, focusing on the provision related to the ODACS, or Outpatient Drug Acquisition Cost Survey. They’ll review the statutory landscape surrounding the survey, recap past attempts by CMS to lower 340B hospital reimbursement, and discuss considerations for hospitals as they contemplate how to respond this time around.

In the intro, the guys review updates to manufacturer 340B policies. Specifically, they discuss a new policy from one manufacturer that conditions 340B pricing access for in-house pharmacies on claim submission requirements.

Avsnitt(93)

Ep 79 | 340B Rebate Model Update

Ep 79 | 340B Rebate Model Update

In this episode, Greg and Rob share initial reactions to the HRSA update on 340B rebate model implementation. They’ll review the communication provided by HRSA on October 30th on their website, as wel...

3 Nov 202552min

Ep 78 |  Government Shutdown, Most Favored Nations Pricing and Direct-to-Consumer Pharmacy Supply Chain Discussion

Ep 78 | Government Shutdown, Most Favored Nations Pricing and Direct-to-Consumer Pharmacy Supply Chain Discussion

In this episode, Greg and Rob chat about what the government shutdown might mean for 340B Program oversight in the short-term. They’ll also discuss a flurry of developments from manufacturers recently...

13 Okt 202533min

Ep 77 | DSH Hospital Threats

Ep 77 | DSH Hospital Threats

In this episode, Greg and Rob are joined by SpendMend colleague Heather Lynch, to talk about how H.R.1 (i.e. One Big Beautiful Bill Act, or OBBBA) could impact 340B covered entities in the long run. T...

29 Sep 202550min

Ep 76 | HRSA DRL Updates & 340B Rebate Comments

Ep 76 | HRSA DRL Updates & 340B Rebate Comments

In this episode, Greg and Rob review recent changes made to the HRSA Audit Data Request List (DRL). They also discuss some of the comments provided by the public to HRSA regarding potential 340B rebat...

15 Sep 20251h 1min

Ep 75 | 340B Rebate Guidance Update – HRSA FAQs

Ep 75 | 340B Rebate Guidance Update – HRSA FAQs

In this episode, Greg and Rob catch up on insights gathered and lessons learned from various forums our team has attended over the last few weeks. Also, they discuss the recently posted FAQ page provi...

1 Sep 202550min

Ep 74 | Annual Hospital Recertification & Proposed Changes to OPAIS

Ep 74 | Annual Hospital Recertification & Proposed Changes to OPAIS

In this episode, Greg and Rob discuss tips for completing the annual 340B hospital recertification process, which is occurring now through early September. They also recap a recent notice in the Feder...

18 Aug 202530min

Ep 73 | Coalition Recap & 340B Rebate Guidance Release

Ep 73 | Coalition Recap & 340B Rebate Guidance Release

In this episode, Greg and Rob share initial thoughts on 340B Rebate Model Guidance released by HRSA on July 31st. They also catch up on some of the hot topics that were generating conversations at the...

11 Aug 202543min

Ep 72 |  Insulin & EpiPen 340B Policy Changes for FQHCs

Ep 72 | Insulin & EpiPen 340B Policy Changes for FQHCs

This week’s episode is a short one but a good one. Rob is out on vacation, so Greg is joined by SpendMend colleague Sabrina Allen to discuss the recent policy changes impacting FQHCs related to a Trum...

21 Juli 202520min

Populärt inom Business & ekonomi

framgangspodden
badfluence
varvet
rss-jossan-nina
rss-svart-marknad
rss-borsens-finest
avanzapodden
svd-tech-brief
uppgang-och-fall
rss-dagen-med-di
fill-or-kill
lastbilspodden
rss-inga-dumma-fragor-om-pengar
dynastin
24fragor
rss-kort-lang-analyspodden-fran-di
rss-den-nya-ekonomin
kapitalet-en-podd-om-ekonomi
bathina-en-podcast
borsmorgon